Khushi Quadri | Pharmacology | Best Researcher Award

Ms. Khushi Quadri | Pharmacology | Best Researcher Award

Research Scholar at SGT COLLEGE OF PHARMACY, India

Khushi Quadri is a passionate and driven researcher in the field of pharmaceutics, with a strong focus on nanotechnology, drug delivery systems, and biomedical applications. She has excelled academically, achieving an impressive 88.6% in her Master’s program at SGT University, Gurugram. Khushi has contributed extensively to the scientific community through publications in reputed journals such as Elsevier and iLiver. Her research spans diverse areas, including neurological disease treatments, biosensors, and eco-friendly nanomaterials. She has presented her work at several national and international conferences, showcasing her ability to effectively communicate complex scientific ideas. Khushi’s dedication to innovation and excellence has earned her recognition in competitions and tech fests. Alongside her academic and research pursuits, she has developed skills in teamwork, communication, and adaptability, making her a well-rounded professional.

Professional Profile

Education

Khushi Quadri has a robust academic foundation in pharmacy and pharmaceutics. She is currently completing her Master’s degree in Pharmaceutics at SGT University, Gurugram (2022-2024), where she has maintained an exceptional 88.6% score. Prior to this, she earned her Bachelor’s degree in Pharmacy from B.S. Anangpuria Institute of Pharmacy, Faridabad, achieving 75.7%. Her earlier education includes a solid performance in Class XII and Class X from Kalka Public School, Alaknanda, with scores of 86.8% and 76%, respectively. This strong educational background reflects her consistency and commitment to academic excellence.

Professional Experience

Khushi has actively engaged in professional academic and research activities. Her experience includes presenting posters at multiple international and national conferences, focusing on innovative topics like eco-friendly nanoparticles, biosensors, and drug delivery systems. She has also participated in numerous workshops, gaining hands-on knowledge in areas like tablet compression, coating techniques, and spectroscopy. Through these engagements, she has honed her research and presentation skills, enabling her to effectively contribute to the scientific community.

Research Interests

Khushi’s research interests lie at the intersection of pharmaceutics, nanotechnology, and biomedical sciences. She is particularly focused on green synthesis of nanoparticles for drug delivery and therapeutic applications, including neurological diseases and cancer treatment. Her work also explores the role of inorganic nanoparticles in water purification, biosensors, and antimicrobial therapies. Her commitment to sustainable research is evident in her studies on eco-friendly materials and their environmental impact.

Research Skills

Khushi Quadri possesses a diverse skill set that complements her research activities. She is proficient in designing and optimizing green synthesis techniques for nanoparticles and evaluating their biomedical applications. Her expertise extends to spectroscopic techniques, including FTIR and UV spectroscopy, and she has a strong grasp of Microsoft Excel and Word for data analysis and documentation. Additionally, her collaborative and adaptable nature allows her to effectively work in multidisciplinary teams, contributing innovative solutions to complex research challenges.

Awards and Honors

Khushi has been recognized for her academic and research excellence through several awards and honors. Notably, she secured 3rd rank in the Synergy Tech Fest 2023 for her project on eco-friendly mosquito repellents. She has also participated in various competitive events, including national conferences and debates, reflecting her proactive engagement with the academic community. Certificates of appreciation for her achievements in CBSE board exams and employability skills further underscore her dedication to personal and professional growth.

Conclusion 🎯

Khushi Quadri has demonstrated commendable achievements in academic performance, research, and conference participation, making her a strong candidate for early-career researcher recognition. However, for a Best Researcher Award, areas like deep specialization, innovation, international collaboration, and leadership experience may need further development.

Publication Top Notes

  1. New Approaches to the Treatment of Metabolic Dysfunction-Associated Steatotic Liver with Natural Products
    • Authors: P. Yadav, K. Quadri, R. Kadian, A. Waziri, P. Agrawal, M.S. Alam
    • Journal/Source: iLIVER
    • Year: 2024
    • Citation: P. Yadav, K. Quadri, R. Kadian, A. Waziri, P. Agrawal, M.S. Alam, “New Approaches to the Treatment of Metabolic Dysfunction-Associated Steatotic Liver with Natural Products,” iLIVER, vol. 100131, 2024.
  2. A New Era of Nanotechnology Applied in Neurological Disease Treatment
    • Authors: A.S.M.S.A. Jayamanti Pandit, Charu Bharti, Surbhi Gupta, Syed Muzammil Munawar
    • Book/Source: Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Insights
    • Year: 2024
    • Citation: A.S.M.S.A. Jayamanti Pandit, Charu Bharti, Surbhi Gupta, Syed Muzammil Munawar, “A New Era of Nanotechnology Applied in Neurological Disease Treatment,” in Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Insights, 2024.
  3. Potential Role of Probiotics in Neurological Disease Treatment
    • Authors: M.S.A. Khushi Quadri, Sagar Thakur, Sushma Chaturvedi, Renu Kadian, Geeta Rawat
    • Book/Source: Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Insights
    • Year: 2024
    • Citation: M.S.A. Khushi Quadri, Sagar Thakur, Sushma Chaturvedi, Renu Kadian, Geeta Rawat, “Potential Role of Probiotics in Neurological Disease Treatment,” in Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Insights, 2024.

 

Seval Bulut | Pharmacology | Best Researcher Award

Assist. Prof. Dr. Seval Bulut | Pharmacology | Best Researcher Award

Erzincan Binali Yıldırım University at Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Turkey

Dr. Seval Bulut is an accomplished researcher and Assistant Professor in the Department of Pharmacology at Erzincan Binali Yıldırım University in Turkey. With an extensive background in medicine and pharmacology, her research focuses on drug safety, therapeutic interventions, and protective effects of natural extracts on organ function. Dr. Bulut’s prolific work includes 45 research articles published in leading SSCI and SCIE journals, where she has explored biochemical and histopathological mechanisms underlying drug-induced toxicity and protective pharmacological agents. Her studies span organ systems and conditions such as hepatotoxicity, renal damage, reproductive health, and ischemic syndrome, showcasing a robust interdisciplinary approach. Dr. Bulut has contributed to advancing pharmacological research with her findings on natural compounds and coenzyme Q10’s efficacy in mitigating organ dysfunction. Her academic influence extends through her roles as a physician and educator, mentoring emerging researchers in pharmacology. Dr. Bulut’s dedication to drug safety and therapeutic research has not only bolstered her professional reputation but also holds promise for improving patient care and drug efficacy in clinical settings.

Professional Profile

Education

Dr. Seval Bulut’s educational background exemplifies her dedication to the fields of medicine and pharmacology. She earned her MD from Atatürk University Faculty of Medicine in 2001, embarking on her journey as a physician committed to improving patient outcomes. Dr. Bulut later transitioned to academia, pursuing a doctoral program at Erzincan Binali Yıldırım University’s Institute of Health Sciences, Department of Medical Pharmacology. In 2024, she completed her PhD with a thesis titled “The Effect of Liv-52 on Favipiravir-Induced Hepatotoxicity in Rats: Biochemical and Histopathological Evaluation,” demonstrating her keen focus on pharmacology, particularly in drug-induced toxicity. This advanced education has equipped Dr. Bulut with a strong foundation in both clinical and research aspects of pharmacology, enabling her to investigate the biochemical mechanisms of drug interactions and develop therapeutic strategies for organ protection. Her academic journey reflects a consistent focus on integrating medical practice with pharmacological research to address real-world health challenges.

Professional Experience

Dr. Bulut’s professional experience is rooted in her dual roles as a clinician and researcher. She initially practiced medicine across various health institutions from 2001 to 2010, gaining valuable hands-on experience that provided her with a comprehensive understanding of patient care. Transitioning to a Family Physician role between 2010 and 2024, she developed a strong patient-focused perspective, which later became integral to her research approach. Currently, Dr. Bulut serves as an Assistant Professor in the Department of Pharmacology at Erzincan Binali Yıldırım University. In this academic role, she has combined her clinical insights with research expertise, conducting studies on pharmacological interventions to protect against drug-induced organ damage. Her extensive background in clinical medicine complements her current research endeavors, where she investigates the biochemical and histopathological mechanisms of pharmacological agents. This blend of professional experience positions Dr. Bulut as a knowledgeable researcher who brings both theoretical and practical insights to her field.

Research Interests

Dr. Seval Bulut’s research interests lie at the intersection of pharmacology, toxicology, and therapeutic interventions. She is particularly focused on understanding drug-induced toxicity and the protective effects of natural compounds on organ systems. Her work has centered on evaluating the biochemical and histopathological mechanisms of various pharmacological agents, including the impact of drugs such as favipiravir on liver health. Dr. Bulut’s studies also explore natural compounds like coenzyme Q10 and cinnamon extract for their potential to mitigate organ dysfunction, particularly in kidney and liver applications. Additionally, she has examined the effects of pharmaceutical compounds on reproductive health, as well as protective pharmacological strategies for conditions such as ischemic ocular syndrome. Her research contributes to improving drug safety and efficacy, providing insights that could lead to safer clinical applications and therapeutic innovations. Through her interdisciplinary research, Dr. Bulut aims to enhance the understanding of pharmacodynamics and pharmacokinetics in therapeutic contexts.

Research Skills

Dr. Seval Bulut has developed a broad set of research skills essential to her pharmacological studies. She is adept in designing and conducting in vivo experiments, specifically using animal models to assess drug efficacy and toxicity. Her skills in biochemical and histopathological analysis are evidenced in her research on drug-induced organ toxicity, where she utilizes various biochemical markers and staining techniques to evaluate cellular and tissue changes. Dr. Bulut is also proficient in data analysis and interpretation, crucial for her work in pharmacology and toxicology, where she frequently analyzes complex datasets to draw meaningful conclusions about drug interactions and therapeutic effects. Additionally, she is skilled in the ethical and methodological aspects of animal research, ensuring that her studies meet rigorous scientific standards. Her collaborative skills are reflected in her ability to work alongside other professionals, contributing to a multidisciplinary approach in her studies on pharmacological agents and natural compounds.

Awards and Honors

Dr. Seval Bulut’s academic and professional achievements have earned her recognition in the scientific community. Her prolific publication record includes 45 research articles indexed in SSCI and SCIE, which demonstrates her commitment to advancing pharmacological research. These publications span influential journals, highlighting her research’s impact and relevance in the field. Dr. Bulut’s focus on drug safety, natural therapeutics, and organ protection has led to invitations to present her findings at international congresses, further establishing her as a respected voice in pharmacology. Additionally, her progression from a practicing physician to a PhD-holder and Assistant Professor in a highly specialized research area reflects her dedication to both medical practice and academia. Although specific awards are not listed, her consistent scholarly contributions and active research agenda signal her as a promising candidate for future awards recognizing excellence in research and contributions to pharmacology. Her work holds significant implications for clinical safety and therapeutic advancements, which are critical areas of modern medical research.

Conclusion

Dr. Seval Bulut is a strong candidate for the Best Researcher Award due to her significant contributions to pharmacological research and her commitment to addressing drug safety and therapeutic efficacy. Her expertise, publication volume, and applied research focus on organ protection and biochemical evaluation highlight her as an impactful researcher. Continued emphasis on international collaboration, active conference participation, and funding pursuit could further elevate her profile and ensure sustained research advancements.

Publications Top Notes

  1. Title: Effect of ethyl acetate extract from Usnea longissima on chemotherapy-associated multiple organ dysfunction in rats
    Authors: Bingul, E., Bulut, S., Mammadov, R., Suleyman, H., Mendil, A.S.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 181
    Article ID: 117636
  2. Title: The hormonal mechanism of the effects of meperidine, sertraline, tianeptine, and their combinations on reproductive functions in female rats
    Authors: Yilmaz, B.K., Suleyman, Z., Suleyman, B., Coban, T.A., Suleyman, H.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 178
    Article ID: 117160
  3. Title: Lacidipine, thiamine pyrophosphate and their combination on the ocular ischemic syndrome induced by bilateral common carotid artery ligation
    Authors: Cicek, I., Somuncu, A.M., Altuner, D., Tastan, T.B., Suleyman, H.
    Journal: International Journal of Ophthalmology
    Year: 2024
    Volume: 17, Issue 5
    Pages: 815–821
  4. Title: Effects of adenosine triphosphate, Lacidipine, and Benidipine on 5-fluorouracil-induced kidney damage in rats
    Authors: Dagel, T., Altuner, D., Suleyman, B., Gulaboglu, M., Suleyman, H.
    Journal: European Review for Medical and Pharmacological Sciences
    Year: 2024
    Volume: 28, Issue 6
    Pages: 2538–2549
  5. Title: Comparative study of the protective effects of coenzyme Q10 and cinnamon extract on possible kidney damage and dysfunction of amiodarone in rats
    Authors: Ekici, O., Gul, A., Keskin, E., Gunay, M., Suleyman, H.
    Journal: Clinical and Experimental Nephrology
    Year: 2024
  6. Title: Protective effects of thiamine pyrophosphate and cinnamon against oxidative liver damage induced by an isoniazid and rifampicin combination in rats
    Authors: Yeter, B., Mammadov, R., Koc, Z., Gulaboglu, M., Suleyman, H.
    Journal: Investigacion Clinica (Venezuela)
    Year: 2024
    Volume: 65, Issue 3
    Pages: 321–334
  7. Title: Protective effect of cinnamon extract against cobalt-induced multiple organ damage in rats
    Authors: Isik, B., Suleyman, B., Mammadov, R., Coban, T.A., Suleyman, H.
    Journal: Frontiers in Pharmacology
    Year: 2024
    Volume: 15
    Article ID: 1384181
  8. Title: Role of L-, N- and T-type calcium channels in achieving maximum analgesic and minimum toxic effect of tramadol
    Authors: Yilmaz, M., Suleyman, B., Mammadov, R., Coskun, R., Suleyman, H.
    Journal: Acta Poloniae Pharmaceutica – Drug Research
    Year: 2024
    Volume: 81, Issue 1
    Pages: 135–143
  9. Title: Protective Effect of Ramipril Against Oxidant and Proinflammatory Cytokine Damage Induced by Ischemia-Reperfusion in Ovarian Tissue in Rats
    Authors: Ulug, P., Nayki, U., Mammadov, R., Coban, T.A., Suleyman, H.
    Journal: Transplantation Proceedings
    Year: 2024
    Volume: 56, Issue 1
    Pages: 215–222
  10. Title: Effect of pycnogenol on ischemia/reperfusion-induced oxidative and inflammatory damage in the ovaries of rats
    Authors: Dinc, K., Kiremitli, S., Suleyman, B., Altuner, D., Suleyman, H.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2023
    Volume: 22, Issue 11
    Pages: 2297–2303

 

 

Moein Masjedi | Pharmacology | Best Researcher Award

Moein Masjedi | Pharmacology | Best Researcher Award

Moein Masjedi, DarooSazan Sorena Exir Pharmaceutical Company, Iran.

Moein Masjedi is a dedicated researcher in the field of pharmacology, recognized for his innovative contributions to drug development and therapeutic strategies. With a strong academic background and a commitment to advancing scientific knowledge, he has published numerous influential papers that address critical challenges in the field. Awarded the Best Researcher Award for his outstanding research impact, Moein continues to inspire peers and students through his passion for improving health outcomes and enhancing patient care.

Profile:

Education

Moein Masjedi earned his Doctor of Pharmacy degree from Shiraz University of Medical Sciences in Shiraz, Fars, Iran, where he completed his thesis on the drug utilization evaluation of captopril in two coronary care units at Namazi Hospital, achieving a GPA of 15.64 out of 20. He then pursued a Ph.D. in Pharmaceutics at the same institution, focusing on the nose-to-brain delivery of Sumatriptan using chitosan nanoparticles and nanostructured lipid carriers (NLCs), and graduated with a GPA of 17.83 out of 20.

 

Skills 

Moein Masjedi possesses a diverse skill set that enhances his effectiveness as a researcher and collaborator. He excels in strong and collaborative communication, fostering teamwork and idea exchange. His creativity in problem-solving and critical thinking enables him to tackle complex challenges in pharmacology. Demonstrating leadership qualities, he effectively manages projects while prioritizing time management to meet deadlines. Additionally, he is skilled in structural scientific writing and proofreading, ensuring clarity and precision in his research publications. Beyond academia, Moein has a passion for art interpretation and enjoys swimming and yoga, which contribute to his overall well-being and work-life balance.

Areas of Interest:

Moein Masjedi’s research interests focus on innovative drug delivery systems and formulation design. He is particularly passionate about nanoparticulate drug delivery and the optimization of formulations for pulmonary, ocular, topical, and transdermal applications. His work includes designing novel drug delivery systems targeting specific sites such as the pulmonary system, colon, brain, and hair follicles. He explores the use of nanovesicles, lipid, and polymeric nanoparticles for both therapeutic and cosmetic applications. Additionally, Moein is interested in D-optimal optimization of aesthetic formulations and the development of stimuli-responsive or smart polymers for drug delivery. He employs Design of Experiments (DoE) methodologies to optimize formulations and is also engaged in the innovative 3D printing of pharmaceutical dosage forms, aiming to advance the field of pharmaceutics.

Publication Top Notes

  1. Masjedi, M., Izadi, Y., Montahaei, T., Mohammadi, R., Helforoush, M. A., & Rohani Rad, K. (2024). An illustrated review on herbal medicine used for the treatment of female infertility. European Journal of Obstetrics and Gynecology and Reproductive Biology, 0(0).
  2. Dahri, M., Beheshtizadeh, N., Seyedpour, N., Nakhostin-Ansari, A., Aghajani, F., Seyedpour, S., Masjedi, M., Farjadian, F., Maleki, R., & Adibkia, K. (2023). Biomaterial-based delivery platforms for transdermal immunotherapy. Biomedicine & Pharmacotherapy, 165, 115048.
  3. Rezaie, F., Farshbaf, M., Dahri, M., Masjedi, M., Maleki, R., Amini, F., Wirth, J., Moharamzadeh, K., Weber, F. E., & Tayebi, L. (2023). 3D printing of dental prostheses: Current and emerging applications. Journal of Composites Science, 7(2), 80.
  4. Masjedi, M., Montahaei, T., Sharafi, Z., & Jalali, A. (2022). Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology, 103184.
  5. Masjedi, M., & Solhjoo, A. (2022). Does trigonelline help skin tone? Molecular docking studies of trigonelline on the human tyrosinase, formulation, optimization and characterization of an emulgel containing Trigonella foenum‐graecum L. fenugreek standardized hydroalcoholic extract. Journal of Cosmetic Dermatology.
  6. Masjedi, M., & Namazi, S. (2020). Drug utilization evaluation (DUE) of captopril in two coronary care units (CCU) of Namazi Hospital, Shiraz, Iran.
  7. Masjedi, M., & Montahaei, T. (2020). An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: Fabrication, characterization, pharmaceutical, and cosmetic applications. Journal of Drug Delivery Science and Technology, 102234.
  8. Masjedi, M., Azadi, A., Heidari, R., & Mohammadi-Samani, S. (2020). Brain targeted delivery of sumatriptan succinate loaded chitosan nanoparticles: Preparation, in vitro characterization, and (neuro-) pharmacokinetic evaluations. Journal of Drug Delivery Science and Technology, 102179.
  9. Ziaei, A., Davoodian, P., Dadvand, H., Safa, O., Hassanipour, S., Omidi, M., Masjedi, M., Mahmoudikia, F., Rafiee, B., & Fathalipour, M. (2020). Evaluation of the efficacy and safety of melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials, 21(1), 1-3.
  10. Masjedi, M., Azadi, A., Heidari, R., & Mohammadi‐Samani, S. (2020). Nose‐to‐brain delivery of sumatriptan‐loaded nanostructured lipid carriers: Preparation, optimization, characterization, and pharmacokinetic evaluation. Journal of Pharmacy and Pharmacology, 72(10), 1341-1351.